Promethazine
PHENERGAN, PROMETHEGAN
Phenothiazine
NADAC/unit
$0.0414
Active Shortage
Tier 1: 161.1%
PA Req: 277.2%
16 Manufacturers
36 ANDAs
Promethazine treats psychotic disorders and severe nausea by blocking dopamine receptors.
vs. brand PHENERGAN: Generic saves up to 100% per unit
Active Shortages
2023-11-21 Unavailable, XGen Pharmaceuticals DJB, Inc.
2023-11-21 This presentation is temporarily on backorder., Hikma Pharmaceuticals USA, Inc.
2023-11-21 Additional lots are scheduled to be manufactured. Product will be made available as it is released., Hikma Pharmaceuticals USA, Inc.
2023-11-21 Additional lots are scheduled to be manufactured. Product will be made available as it is released., Hikma Pharmaceuticals USA, Inc.
2023-11-21 Additional lots are scheduled to be manufactured. Product will be made available as it is released., Hikma Pharmaceuticals USA, Inc.
Generic Manufacturers
AMNEAL PHARMACEUTICALS NY LLCANNORA PHARMA PRIVATE LTDCHARTWELL RX SCIENCES LLCCOSETTE PHARMACEUTICALS INCHIKMA PHARMACEUTICALS USA INCKVK TECH INCPADAGIS ISRAEL PHARMACEUTICALS LTDPHARMACEUTICAL ASSOCIATES INCPHARMOBEDIENT CONSULTING LLCPRINSTON PHARMACEUTICAL INCQUAGEN PHARMACEUTICALS LLCSANDOZ INCSTRIDES PHARMA GLOBAL PTE LTDWATSON LABORATORIES INCXGEN PHARMACEUTICALS DJB INCZYDUS PHARMACEUTICALS USA INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.